Matthew Ingham
CUIMC/Herbert Irving Pavilion
Office
(212) 305-5098
161 Fort Washington Avenue New York, NY 10032
About
Dr. Ingham specializes in the care of patients with sarcoma and gastrointestinal cancers and is also an active member of the experimental therapeutics unit. His research focuses on the development and clinical evaluation of new treatments for patients with sarcoma. He leads a National Cancer Institute (NCI) sponsored clinical trial evaluating a new treatment approach for uterine leiomyosarcoma based on research conducted at Columbia University. He also leads several other investigator-initiated clinical trials evaluating new targeted and immunotherapy based treatment approaches for leiomyosarcoma, liposarcoma and other types of sarcoma. He is the author of two recent authoritative reviews on the treatment of sarcoma published in the Journal of Clinical Oncology. He is the recipient of the 2019 Conquer Cancer Foundation of ASCO Career Development Award from the Sarcoma Foundation of America in recognition of his research and was also named a 2019 NextGen Innovator by HemOnc Today, among other awards and honors. His overall goal is to provide patients with compassionate oncologic care and access to the most promising treatment approaches.
Matthew Ingham
Dr. Ingham is Assistant Professor of Medicine in the Division of Hematology and Oncology at New York Presbyterian Hospital/Columbia University Medical Center. He received his medical degree from the University of Massachusetts Medical School and completed internship and residency training in Internal Medicine at New York University Medical Center, where he served as Chief Resident. He then completed fellowship training in Hematology and Medical Oncology at New York Presbyterian Hospital/Columbia University Medical Center where he served as Chief Fellow.Dr. Ingham specializes in the care of patients with sarcoma and gastrointestinal cancers and is also an active member of the experimental therapeutics unit. His research focuses on the development and clinical evaluation of new treatments for patients with sarcoma. He leads a National Cancer Institute (NCI) sponsored clinical trial evaluating a new treatment approach for uterine leiomyosarcoma based on research conducted at Columbia University. He also leads several other investigator-initiated clinical trials evaluating new targeted and immunotherapy based treatment approaches for leiomyosarcoma, liposarcoma and other types of sarcoma. He is the author of two recent authoritative reviews on the treatment of sarcoma published in the Journal of Clinical Oncology. He is the recipient of the 2019 Conquer Cancer Foundation of ASCO Career Development Award from the Sarcoma Foundation of America in recognition of his research and was also named a 2019 NextGen Innovator by HemOnc Today, among other awards and honors. His overall goal is to provide patients with compassionate oncologic care and access to the most promising treatment approaches.
Primary Specialty
Internist
Practice
CUIMC/Herbert Irving Pavilion
Gender
Male
Accepting New Patients
Insurances Accepted
UnitedHealthcare, Emblem/Hip, Empire Blue Cross Blue Shield Healthplus, WellCare, MVP Health Care, Healthfirst, RiverSpring, Magnacare (National), Fidelis Care, Medicare, Multiplan, Local 1199, World Trade Center Health Plan, CIGNA, Affinity Health Plan, Emblem/GHI, VNSNY CHOICE, AETNA, Empire Blue Cross/Blue Shield
Degrees
Medical Doctor
Office Name
CUIMC/Herbert Irving Pavilion
Services
Matthew Ingham provides internal medicine in New York, NY. Matthew Ingham is listed as an internist, which is a physician who studies Internal Medicine for adults.
To learn more, or to make an appointment with CUIMC/Herbert Irving Pavilion in New York, NY, please call (212) 305-5098. Additional Services Surgeon, Oncologist, Hematologist, Doctor
To learn more, or to make an appointment with CUIMC/Herbert Irving Pavilion in New York, NY, please call (212) 305-5098. Additional Services Surgeon, Oncologist, Hematologist, Doctor
Consumer Feedback
Add a Review
There are no recent reviews. Be the first!
©2024 Wellness®.com is a registered trademark of Wellness.com, Inc. 